We are live on ! Find out more
DBG

De Burlo Group Portfolio holdings

AUM $441M
1-Year Est. Return 21.21%
This Fund
S&P 500
This Quarter Est. Return
-7.59%
1 Year Est. Return
+21.21%
3 Year Est. Return
+98.05%
5 Year Est. Return
+220.33%
10 Year Est. Return
+1,846.98%
AUM
$351M
AUM Growth
-$186M
Cap. Flow
-$133M
Cap. Flow %
-37.85%
Top 10 Hldgs %
76.44%
Holding
207
New
37
Increased
22
Reduced
25
Closed
123

Top Buys

Rank Stock Value
1
PG icon
Procter & Gamble
PG
+$35.7M
2
MCK icon
McKesson
MCK
+$33M
3
ELV icon
Elevance Health
ELV
+$28.2M
4
EOG icon
EOG Resources
EOG
+$26.4M
5
NVO
Novo Nordisk
NVO
+$26.2M

Top Sells

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$27.1M
2
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$24.3M
3
UNH icon
UnitedHealth
UNH
+$22.6M
4
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$21M
5
MA icon
Mastercard
MA
+$20.4M

Sector Composition

Rank Sector Weight
1 Healthcare 28.18%
2 Consumer Staples 20.19%
3 Technology 15.79%
4 Energy 12.08%
5 Financials 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AMT icon
76
American Tower
AMT
$78.6B
$230K 0.07%
898
-13,236
-94% -$3.32M
SPY icon
77
State Street SPDR S&P 500 ETF Trust
SPY
$778B
$226K 0.06%
599
+484
+421% +$198K
AMGN icon
78
Amgen
AMGN
$203B
$215K 0.06%
882
+827
+1,504% +$203K
YUM icon
79
Yum! Brands
YUM
$40.9B
$214K 0.06%
1,883
+1,211
+180% +$141K
EW icon
80
Edwards Lifesciences
EW
$49.4B
$209K 0.06%
2,200
-17,750
-89% -$1.84M
BAC icon
81
Bank of America
BAC
$435B
$208K 0.06%
6,682
+3,850
+136% +$139K
DE icon
82
Deere & Co
DE
$166B
$202K 0.06%
+674
New +$248K
NUE icon
83
Nucor
NUE
$55.5B
$200K 0.06%
1,920
-42,480
-96% -$5.75M
FIRY
84
Firy Inc
FIRY
$127M
$17K ﹤0.01%
+700
New +$27.3K
ACN icon
85
Accenture
ACN
$88.8B
– –
-30
Closed -$10.1K
ADI icon
86
Analog Devices
ADI
$180B
– –
-200
Closed -$33K
AFL icon
87
Aflac
AFL
$63.9B
– –
-900
Closed -$58K
AGEN
88
Agenus
AGEN
$253M
– –
-5
Closed -$246
AJG icon
89
Arthur J. Gallagher & Co
AJG
$63.1B
– –
-33
Closed -$5.76K
AKAM icon
90
Akamai
AKAM
$17.1B
– –
-221
Closed -$26.4K
AMED
91
DELISTED
Amedisys
AMED
– –
-50
Closed -$8.61K
ANET icon
92
Arista Networks
ANET
$220B
– –
-149,472
Closed -$5.19M
APD icon
93
Air Products & Chemicals
APD
$66.1B
– –
-500
Closed -$125K
ATO icon
94
Atmos Energy
ATO
$30B
– –
-8,050
Closed -$962K
AWK icon
95
American Water Works
AWK
$26.5B
– –
-7,950
Closed -$1.32M
AXP icon
96
American Express
AXP
$219B
– –
-45
Closed -$8.41K
AZN icon
97
AstraZeneca
AZN
$263B
– –
-8,382
Closed -$1.11M
BCE icon
98
BCE
BCE
$19.9B
– –
-43,550
Closed -$2.42M
BG icon
99
Bunge Global
BG
$23.9B
– –
-92,000
Closed -$10.2M
BIIB icon
100
Biogen
BIIB
$29.7B
– –
-125
Closed -$26.3K
2 3
4
5 6

Similar funds

ECA
Endeavour Capital Advisors Greenwich, Connecticut $441M AUM 21.38% 1-Year Est. Return
DWML
Decker Wealth Management LLC Nashville, Tennessee $441M AUM
BOA
Birnam Oak Advisors New York $441M AUM 37.12% 1-Year Est. Return
PLU
Performa Ltd (US) Charleston, South Carolina $442M AUM 13.84% 1-Year Est. Return
CPW
Cove Private Wealth Oyster Bay Cove, New York $440M AUM 27.56% 1-Year Est. Return
CAAM
Cape Ann Asset Management London, United Kingdom $440M AUM 96.23% 1-Year Est. Return
SCP
SailingStone Capital Partners Houston, Texas $440M AUM 127.21% 1-Year Est. Return
EFMC
Empire Financial Management Company New York $442M AUM 24.42% 1-Year Est. Return

De Burlo Group's Q2 2022 Portfolio in Review

As of Q2 2022, De Burlo Group held 207 positions worth $351M, down 35% from $537M the previous quarter. Its ten largest holdings account for 76% of the portfolio.

De Burlo Group withdrew a net $133M in Q2 2022, closing 123 positions and reducing 25 holdings. Its most notable exit was Regeneron Pharmaceuticals, an estimated $18.3M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 28% of assets, up from 19% a quarter earlier, followed by Consumer Staples and Technology.

Against the trend, De Burlo Group opened a new position in McKesson worth $33.7M.

  • De Burlo Group's largest Q2 2022 buy was McKesson: 103,170 shares worth $33.7M.
  • De Burlo Group added most to Procter & Gamble in Q2 2022, an estimated $35.7M increase.
  • De Burlo Group's biggest Q2 2022 reduction was Microsoft, cutting an estimated $27.1M.
  • De Burlo Group fully exited Regeneron Pharmaceuticals in Q2 2022, selling an estimated $18.3M.
  • De Burlo Group's ten largest holdings make up 76% of its $351M portfolio in Q2 2022.
  • De Burlo Group opened 37 new positions and closed 123 in Q2 2022.
  • De Burlo Group's portfolio value fell 35% quarter-over-quarter to $351M.

Based on De Burlo Group's 13F filing for Q2 2022, filed 11 Aug 2022.